Aardvark Therapeutics, Inc. Common Stock (AARD) Q1 2025 Annual Earnings
AARD·Reported May 14, 2025·Before market open
Diluted EPS came in at $-0.71, missed the $-0.67 consensus by $0.04.
Diluted EPS
$-0.71missed by $0.04
Consensus: $-0.67
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Aardvark Therapeutics, Inc. Common Stock's Q1 2025 earnings report.
Aardvark Therapeutics, Inc. Common Stock (AARD) reported Q1 2025 earnings on May 14, 2025 before market open.
Aardvark Therapeutics, Inc. Common Stock reported diluted EPS of $-0.71 for Q1 2025.
EPS missed the consensus estimate of $-0.67 by $0.04.
You can read the 10-K periodic report (0000950170-25-047835) directly on SEC EDGAR. The filing index links above go to sec.gov.